The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant PD-1 inhibitor tislelizumab combined with s-1 plus oxaliplatin in patients with local advanced gastric cancer or gastroesophageal junction adenocarcinoma: Interim results of a single-arm, phase II trial.
 
Kaixiong Tao
No Relationships to Disclose
 
Yuping Yin
No Relationships to Disclose
 
Yao Lin
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Ruidong Li
No Relationships to Disclose
 
Weizhen Liu
No Relationships to Disclose
 
Zhen Xiong
No Relationships to Disclose
 
Xiangyu Zeng
No Relationships to Disclose
 
Ming Cai
No Relationships to Disclose
 
Cuanqing Wu
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose